THERANEXUS AND BBDF PRESENT PROGRESS ON THE BATTEN-1 PROGRAM

Lyon, France - Austin, Texas, United States - 2 November 2022 - 6pm CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

Related Keywords

United States , Paris , France General , France , Texas , French , Thierry Lambert , Mathieu Charv , Florence Portejoie , Martin Pierre Laurent , Emyr Lloyd Evans , Cardiff University School Of Biosciences , National Organization For Rare Disorders , Translational Research Conference For The Management , Twitter , Atomic Energy Commission , Batten Disease Foundation , Beyond Batten Disease Foundation , Cardiff University , Translational Research Conference , Cardiff University School , Chief Scientific Officer , French Alternative Energies , Euronext Growth , Rare Disorders , Theranexus , Bbdf , Present , Progress , Thatten , Program , Translational , Research , Conference , Management , Cls , November , 022 , Chicago ,